Parisi Gray Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,437
Closed -$258K 101
2022
Q4
$258K Buy
+1,437
New +$235K 0.13% 84
2022
Q2
Sell
-1,292
Closed -$223K 110
2022
Q1
$223K Buy
1,292
+170
+15% +$28.6K 0.09% 109
2021
Q4
$285K Sell
1,122
-86
-7% -$25.1K 0.11% 106
2021
Q3
$412K Buy
1,208
+1,170
+3,079% +$432K 0.17% 91
2021
Q2
$9K Buy
+38
New +$6.79K ﹤0.01% 456

Other funds holding MRNA

Parisi Gray Wealth Management's MRNA Position: Q1 2023 in Review

Parisi Gray Wealth Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,437 shares — an estimated $258K sold.

Parisi Gray Wealth Management first reported a position in MRNA in Q2 2021 and held it in 5 quarters. The position peaked at $412K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Parisi Gray Wealth Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 1,437 Moderna shares in Q1 2023, an estimated $258K.
  • Parisi Gray Wealth Management first reported a position in Moderna in Q2 2021 and held it in 5 quarters.
  • Parisi Gray Wealth Management's Moderna position peaked at $412K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Parisi Gray Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.